Pharmacoeconomic study of active psoriatic arthritis treatment
Objective: to conduct a clinical and economic analysis of the therapy for adult patients with psoriatic arthritis (PsA) using netakimab, a Russian interleukin-17 inhibitor, in comparison with other biological (b) and targeted synthetic (ts) disease-modifying antirheumatic drugs (DMARDs), available o...
Saved in:
Main Authors: | , |
---|---|
Format: | Article |
Language: | Russian |
Published: |
IRBIS LLC
2025-02-01
|
Series: | Фармакоэкономика |
Subjects: | |
Online Access: | https://www.pharmacoeconomics.ru/jour/article/view/1139 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|